Tango Therapeutics, Inc.
TNGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$130 | -$102 | -$108 | -$58 |
| Dep. & Amort. | $2 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $29 | $19 | $14 | $8 |
| Change in WC | -$32 | -$38 | -$18 | -$11 |
| Other Non-Cash | -$1 | $0 | $2 | $1 |
| Operating Cash Flow | -$132 | -$118 | -$109 | -$60 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$8 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$241 | -$311 | -$209 | -$372 |
| Inv. Sales/Matur. | $328 | $354 | $243 | $191 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $86 | $41 | $26 | -$183 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $342 |
| Stock Issued | $42 | $80 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | $2 | $2 | $15 |
| Financing Cash Flow | $48 | $82 | $2 | $357 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2 | $6 | -$81 | $114 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70 | $64 | $145 | $31 |
| End Cash | $72 | $70 | $64 | $145 |
| Free Cash Flow | -$132 | -$120 | -$117 | -$61 |